← Open Payments lookup

NATALY AGABIN: Open Payments

NPI 1083150072 · GROVETOWN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$549 in 29 payments from 11 companies in 2025. Trend: 2023 $894 · 2024 $661 · 2025 $549

Food & beverage: $549
CompanyPaymentsAmount
Novo Nordisk Inc9$180
Abbott Laboratories6$93
PFIZER INC.2$43
Bayer Healthcare Pharmaceuticals Inc.2$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43
Lilly USA, LLC2$39
ABBVIE INC.2$36
AstraZeneca Pharmaceuticals LP1$25
Phadia US Inc.1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17

Products named: Wegovy, Kerendia, CAPLYTA, AIRSUPRA, PREVNAR 20, Ozempic, ELIQUIS, ZEPBOUND.

Industry payments across GA — which companies pay providers there.